Jalid Sehouli

2001–2026 年に発表

242
論文数
32,370
被引用数
91
h 指数
225
i10 指数

被引用数

Jalid Sehouli の年別被引用数1994 年: 被引用 3 件1997 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 5 件2004 年: 被引用 8 件2005 年: 被引用 12 件2006 年: 被引用 20 件2007 年: 被引用 24 件2008 年: 被引用 71 件2009 年: 被引用 74 件2010 年: 被引用 82 件2011 年: 被引用 127 件2012 年: 被引用 135 件2013 年: 被引用 142 件2014 年: 被引用 179 件2015 年: 被引用 125 件2016 年: 被引用 192 件2017 年: 被引用 193 件2018 年: 被引用 162 件2019 年: 被引用 818 件2020 年: 被引用 1,173 件2021 年: 被引用 1,442 件2022 年: 被引用 1,248 件2023 年: 被引用 972 件2024 年: 被引用 1,758 件2025 年: 被引用 884 件2026 年: 被引用 25 件1995〜1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,426 件、この内訳の 18.2%中国: 引用元論文 1,566 件、この内訳の 11.8%イタリア: 引用元論文 965 件、この内訳の 7.2%イギリス: 引用元論文 885 件、この内訳の 6.6%ドイツ: 引用元論文 815 件、この内訳の 6.1%フランス: 引用元論文 595 件、この内訳の 4.5%スペイン: 引用元論文 503 件、この内訳の 3.8%カナダ: 引用元論文 492 件、この内訳の 3.7%オランダ: 引用元論文 365 件、この内訳の 2.7%日本: 引用元論文 362 件、この内訳の 2.7%オーストラリア: 引用元論文 346 件、この内訳の 2.6%ベルギー: 引用元論文 287 件、この内訳の 2.2%
0%18.2%その他 27.9%

分野

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology24.9%
  • Immunology and Microbiology3%
  • Engineering1.2%
  • Materials Science1.1%
  • Computer Science0.5%
  • その他2.4%

トピック

  • Ovarian cancer diagnosis and treatment10.4%
  • Endometrial and Cervical Cancer Treatments6.4%
  • PARP inhibition in cancer therapy5.2%
  • Cancer Immunotherapy and Biomarkers2.5%
  • MicroRNA in disease regulation1.8%
  • Extracellular vesicles in disease1.7%
  • その他72%

共著者

全論文

検索で開く
  1. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 2,040

  2. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2020 被引用: 1,933

  3. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 840

  4. Ovarian cancer

    著者: , , , , , - Nature Reviews Disease Primers 2016 被引用: 1,291

  5. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio González-Martı́n, Viola Heinzelmann‐Schwarz, Florence Joly, J.W. Kim, Frédéric Kridelka, Jonathan A. Ledermann, Domenica Lorusso, Sven� Mahner, W. Glenn McCluggage, Iain A. McNeish, Mikio Mikami, Mansoor Raza Mirza, Philippe Morice, Shibani Nicum, Siel Olbrecht, Dearbhaile M. O’Donnell, Patricia Pautier, François Planchamp, Sandro Pignata, Denis Querleu, Isabelle Ray‐Coquard, Alexandros Rodolakis, Jalid Sehouli, Fatih Selçukbırıcık, Cristiana Sessa, Nilanchali Singh, David S.P. Tan, D. Timmerman, Germana Tognon, Jacobus van der Velden, Ignace Vergote, Petronella O. Witteveen, Alain G. Zeimet - Annals of Oncology 2019 被引用: 1,165

  6. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophia Frentzas, Ganessan Kichendasse, Bo Gao, Tarek Meniawy, Linda Mileshkin, Gary Richardson, Felicia Roncolato, Jean‐François Baurain, Maryam Bourhaba, Eveline Cuypere, Philip R. Debruyne, Hannelore Denys, Frédéric Forget, Brigitte Honhon, E. Joosens, Els Van Nieuwenhuysen, Vanessa da Costa Miranda, Andréia Cristina de Melo, Joao Daniel Guedes, Charles Andreé Joseph de Pádua, Nicolas Lazaretti, Carolina Martins Vieira, André Mattar, Daniela Neves Palmeiro, Christina Pimentel Oppermann Kussler, Pedro Emanuel Rubini Liedke, João Soares Nunes, Katsuki Arima Tiscoski, Allan Covens, Lara De Guerké, Prafull Ghatage, Lucy Gilbert, Susie Lau, Amit M. Oza, Diane Provencher, Omar Touhami, Congzhu Li, Danbo Wang, Ge Lou, Zhu Genhai, Guiling Li, Shi Hong, Hong Zheng, Wen Hongwu, Jihong Liu, Jing Wang, Ke Wang, Jiang Kui, Li Li, Wang Li, Hao Min, Qi Zhou, Gao Qinglei, Sihai Liao, Zhang Songling, Zhao Weidong, Xiaohua Wu, Wuliang Wang, Rutie Yin, Cheng Ying, Yu Zhang, Liang Zhiqing, Fernando Contreras Mejía, Ángel Luis Martín de Francisco Hernández, Carolina Ortiz Lopez, Carlos Javier Pacheco, Pedro Luis Ramos Guette, Jaime Rendon Pereira, Julian Rivera Diaz, Tomás Sánchez Villegas ほか 156 名 - Journal of Clinical Oncology 2023 被引用: 331

  7. A Phase 3 Trial of Bevacizumab in Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 2,152

  8. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 339

  9. Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 406

  10. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarper Toker, Stephen J. O’Keefe, Sandro Pignata, Linda Duska - The Lancet 2024 被引用: 349

  11. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan A. Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matías‐Guiu, Philippe Morice, Hans W. Nijman, Remi A. Nout, Melanie Powell, Denis Querleu, Mansoor Raza Mirza, Nicholas Reed, Alexandros Rodolakis, Helga B. Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke M. Westermann, Alain G. Zeimet - Annals of Oncology 2015 被引用: 1,380

  12. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Alejandro Pérez Fidalgo, Sandro Pignata, Pedro T. Ramírez, Isabelle Ray‐Coquard, Ignacio Romero, Giovanni Scambia, Jalid Sehouli, Ronnie Shapira‐Frommer, Sudha Sundar, David S.P. Tan, Çağatay Taşkıran, Willemien J. van Driel, Ignace Vergote, François Planchamp, Cristiana Sessa, Anna Fagotti - Annals of Oncology 2024 被引用: 284

  13. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 600

  14. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids

    著者: , , , , , , , , , , , - Nature Communications 2015 被引用: 459

  15. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 315

  16. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on behalf of the ATALANTE/ENGOT-ov29 Investigators, Jean‐Emmanuel Kurtz, Sophie Abadie‐Lacourtoisie, Cyril Abdeddaim, J. Alexandre, P. Augereau, D. Avenin, M. Azémar, Nabil Baba-Hamed, Olivia Bally, Jérôme Barrière, Fernando Bazán, Dominique Berton, Nathalie Bonichon-Lamichhane, Nathalie Bonnin, Elouen Boughalem, R. Boustany Grenier, Pierre-Emmanuel Brachet, Fabien Brocard, Émilie Bultot-Boissier, Maria Cappiello-Bataller, H. Castanie, L. Chaigneau, Camille Chakiba, Dorothée Chocteau-Bouju, Pierre Combe, Aurélie Comte, Elodie Coquan, Cristina Costan, P. Cottu, L. Crouzet, H. Curé, Jérôme Dauba, Hussain Dawood, Laure De Cock, T. De La Motte Rouge, C. Debelleix, Catherine Delbaldo, Martin Demarchi, Marion Deslandres, Raymond Despax, Véronique D’Hondt, Anne Françoise DILLIES-LEGRAIN, A Donnadieu, C. Dubot, Jean Marc Extra, Michel Fabbro, Claire Falandry, F. Fiteni, Anne Floquet, Philippe Follana, Jean‐Sébastien Frenel, G. Freyer, D. Garbay-Decoopman, Céline Gavoille, V. Girre, Laurence Gladieff, F. Goldwasser, Alain Gratet, Jean‐Christophe Grenier, Anne‐Claire Hardy‐Bessard, Pierre‐Etienne Heudel, Florence Joly, A. Jouinot, Emilie Kalbacher, Marie‐Christine Kaminsky, Laurence Lancry-Lecomte, R. Largillier, Fanny Le Du, Alexandra Léary ほか 89 名 - Journal of Clinical Oncology 2023 被引用: 103

  17. MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 153

  18. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susana Banerjee, Massimo Barberis, M.P. Barretina Ginesta, J.F. Baurain, Margherita Bignami, Line Bjørge, Paweł Blecharz, Ilan Bruchim, ME Capilna, Nicoletta Cerana, Americo Cicchetti, Dearbhaile Catherine Collins, Nicole Concin, Maurizio D’Incalci, Brittany A. Davidson, Thibault De La Motte Rouge, Pierandrea De Iaco, Fuat Demirkıran, Hannelore Denys, Thilo Doerk, Anne Dørum, Annamaria Ferrero, Alejandro Perez Fidalgo, Maurizio Genuardi, Laurence Gladieff, Rosalind Glasspool, Christoph Grimm, Murat Gültekin, E. Hahnen, Annette Hasenburg, Alinta Hegmane, Viola Heinzelmann, Estrid Høgdall, Ramūnas Janavičius, Sonata Jarmalaitė, Roshni Kalachand, Radka Kaneva, Saadettin Kılıçkap, Roman Kocián, D. Kolencik, Rebecca Kristeleit, Anna Kryzhanivska, Alexandra Léary, Birthe Lemley, Marjolijn J. L. Ligtenberg, José Antonio López‐Guerrero, Christopher J. Lord, E. Åvall‐Lundqvist, Johanna Mäenpää, Sven Mahner, Frederik Marmé, Christian Marth, Iain A. McNeish, Sabine Merkelbach‐Bruse, Marian J.E. Mourits, Nicola Normanno, Ana Oaknin, Kristiina Ojamaa, C. Papdimitriou, F. Penault-Llorca, Anna Myriam Perrone, Sandro Pignata, Eli Pikarsky, Étienne Rouleau, María Jesús Rubio, Anna Sapino, Barbara Schmalfeldt, Jalid Sehouli, Roni Shapira, Karina Dahl Steffensen ほか 12 名 - Annals of Oncology 2021 被引用: 164

  19. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

    著者: , , , , , , , , , - BMC Cancer 2018 被引用: 257

  20. ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer

    著者: , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2023 被引用: 74

  21. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM

    著者: , , , , , , , , , - Gynecologic Oncology 2007 被引用: 400

  22. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarper Toker, Stephen J. O’Keefe, Sandro Pignata, Linda Duska - The Lancet 2024 被引用: 161

  23. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Emmanuel Kurtz, Sven Ackermann, C. Anthuber, Mustafa Aydoğdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Ulrich Canzler, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Ahmed El-Balat, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, R. Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Gräfe, Martin Grießhammer, Eva‐Maria Grischke, Isolde Gröll, Martina Gropp‐Meier, Dietrich Hager, Volker Hanf, Carla Hannig, Peer Hantschmann, Philipp Harter, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, T Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon‐Dschun Ko, H. Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, P. Ledwon, Sabine Lemster, B. Lex, Clemens Liebrich, Ralf Lorenz, Hans‐Joachim Lück, Sven� Mahner, Peter Mallmann, Frederik Marmé, Werner Meier, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober ほか 87 名 - The Lancet Oncology 2020 被引用: 162

  24. The systemic treatment of recurrent ovarian cancer revisited

    著者: , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 158